Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Stage I-III Hodgkin's disease: outcome and pattern of failure following treatment with radiation therapy and chemotherapy in a modern era.
Hematology. 2002 Feb;7(1):43-50. doi: 10.1080/10245330290020117.
Hematology. 2002.
PMID: 12171776
HIF1A expression in localized prostate cancer treated with dose escalation radiation therapy.
Zapatero A, Morente M, de Vidales CM, Adrados M, Lopez C, Nieto S, González MJ, Arellano R, Conde AC, Vicente FG.
Zapatero A, et al. Among authors: de vidales cm.
Cancer Biomark. 2015;15(1):41-6. doi: 10.3233/CBM-140439.
Cancer Biomark. 2015.
PMID: 25524941
Item in Clipboard
High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial.
Zapatero A, Guerrero A, Maldonado X, Alvarez A, Gonzalez San Segundo C, Cabeza Rodríguez MA, Macias V, Pedro Olive A, Casas F, Boladeras A, de Vidales CM, Vazquez de la Torre ML, Villà S, Perez de la Haza A, Calvo FA.
Zapatero A, et al. Among authors: de vidales cm.
Lancet Oncol. 2015 Mar;16(3):320-7. doi: 10.1016/S1470-2045(15)70045-8. Epub 2015 Feb 19.
Lancet Oncol. 2015.
PMID: 25702876
Clinical Trial.
Item in Clipboard
High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial.
Zapatero A, Guerrero A, Maldonado X, Álvarez A, San-Segundo CG, Rodríguez MÁC, Solé JM, Olivé AP, Casas F, Boladeras A, de Vidales CM, de la Torre MLV, Vara S, Sanz JL, Calvo FA.
Zapatero A, et al. Among authors: de vidales cm.
Lancet Oncol. 2022 May;23(5):671-681. doi: 10.1016/S1470-2045(22)00190-5. Epub 2022 Apr 12.
Lancet Oncol. 2022.
PMID: 35427469
Clinical Trial.
Item in Clipboard
Item in Clipboard
Item in Clipboard
Cite
Cite